ResultsIQ

ResultsIQ › Latest results › Qualitek Labs Ltd

Qualitek Labs Ltd business update summary

NSE: QLL · BSE: 544091

Business update of 14 Nov 2025, summarised by AI from the filing.

Better operating leverage and margin expansion expected in H2 FY26 as utilisation improves across the expanded lab network.

Key takeaways

  1. Guidance Better operating leverage and margin expansion expected in H2 FY26 as utilisation improves across the expanded lab network.
  2. Change EBITDA and PAT margins were lower than H2 FY25 on consolidation-phase dynamics including ITCPL integration and Noida and Pune ramp-up.
  3. Risk New labs incurred ₹3.3 cr EBITDA loss in H1 FY26, impacting the consolidated EBITDA margin.

Original filing on BSE

Qualitek Labs Ltd earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.